Objective: To perform a meta-analysis to evaluate studies investigating the association between ATG16L1 gene polymorphism and Crohn's disease. Methods: PubMed, Embase and Web of Science databases were searched for all studies focusing on the association of ATG16L1 and Crohn's disease. Combined odds ratios with 95% confidence intervals were calculated for four genetic models (allelic model: G allele versus A allele; additive model: GG versus AA; dominant model: GA þ GG versus AA; recessive model: GG versus GA þ AA) using either a random effects or fixed effects model. Results: A total of 47 case-control studies involving 18 638 cases and 30 181 controls were included in the final meta-analysis. There was a significant association between ATG16L1 and Crohn's disease for all four genetic models. Significant associations were also shown in subgroup analyses when stratified by study design (population-or hospital-based). Conclusion: In this meta-analysis, the ATG16L1 genotype was significantly associated with the risk of developing Crohn's disease.
Introduction
Crohn's disease is a type of inflammatory bowel disease associated with chronic relapsing inflammation of the digestive tract anywhere from the mouth to the anus. the interactions of genetic, environmental and microbial factors. Among these, genetic factors may be responsible for a major component of disease susceptibility. 2 The role of autophagy processes in the development of inflammatory bowel disease is attracting increasing attention. 3 It is possible that genes involved in the autophagy pathway may contribute to the pathogenesis of Crohn's disease. The autophagy-related 16-like 1 (ATG16L1) gene encodes an important protein involved in the formation of autophagosomes during autophagy. 4 Genome-wide association studies have shown an association between ATG16L1 polymorphism involving an amino acid change at position 300 and increased susceptibility to Crohn's disease. 5, 6 This substitution of threonine with alanine is the result of a single nucleotide polymorphism in which adenine (A) is replaced with guanine (G). This association has been examined in numerous studies, but the results have been inconsistent. The present meta-analysis was designed to evaluate the association between ATG16L1 and Crohn's disease using the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) criteria. 7 , and also references from articles, reviews and abstracts presented at meetings of related scientific societies. The following search terms were used: (''ATG16L1'') AND (''Crohn's disease'' OR ''inflammatory bowel diseases'') AND (''polymorphism'' OR ''mutation'' OR ''variant'' OR ''genotype''). Studies were limited to those published in English.
Materials and methods

Literature search
Inclusion criteria and quality assessment
The same two investigators independently screened each of the titles, abstracts and full texts to determine whether the studies met the following criteria: (i) evaluation of the association of Crohn's disease and ATG16L1 polymorphism; (ii) case-control design; (iii) sufficient data for the estimation of odds ratios (ORs) and 95% confidence intervals (CIs). In addition, a quality assessment was performed on all included studies using the Newcastle-Ottawa Scale (NOS) as described elsewhere. 8 
Data extraction
The following data were collected from each study included in the meta-analysis: first author's name, publication date, country, total numbers of cases and controls, and frequency of ATG16L1 genotypes in cases and controls.
Statistical analyses
Strength of agreement between the investigators regarding study selection was evaluated using the Kappa statistic. The combined ORs and 95% CIs were calculated for the allelic model (G allele versus A allele), the additive model (GG versus AA), the dominant model (GA þ GG versus AA) and the recessive model (GG versus GA þ AA) using either the random effects model 9 or the fixed effects model. 10 Galbraith plots were created to graphically assess the source of any heterogeneity. Publication bias was analyzed using Begg's funnel plots and Egger's test, with a P-value < 0.05 being considered representative of statistically significant publication bias.
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Conformity with the HardyWeinberg equilibrium amongst the controls was determined using the 2 -square test and was considered to be in agreement when the P-value is 0.05. All statistical analyses were performed using Stata statistical software version 11.0 (StataCorp, College Station, TX, USA).
Results
Study characteristics
A total of 843 potentially relevant articles were initially identified. After exclusion of duplicate studies and application of the inclusion criteria, a total of 44 articles were included in the qualitative synthesis ( Figure 1 ). Bu¨ning et al. 13 contained three separate case-control studies and Fowler et al. 19 contained two separate case-control studies; therefore, a total of 47 case-control studies involving 18 638 cases and 30 181 controls were included in the final metaanalysis. The main characteristics of these studies are given in Table 1 .
Quantitative synthesis
When all the studies were pooled in the meta-analysis, a significant association was seen between ATG16L1 and Crohn's disease Figure 5 ). When stratified by study design (population-or hospital-based), a significant association between ATG16L1 and Crohn's disease was still seen in all four genetic models ( Table 2) .
Sensitivity analyses
Sensitivity analyses were conducted to determine whether modification of the inclusion Figure 2 . Forest plot of the association between ATG16L1 and Crohn's disease using the allelic model (G allele versus A allele). The pooled odds ratio (OR) and 95% confidence intervals (CI) are indicated by the diamond. Percentage weights were calculated using a random effects model.
criteria of the meta-analysis affected the final results. When the included studies were limited to those conforming to the HardyWeinberg equilibrium (P 0.05), the pooled ORs of these 33 studies were not materially different from those of the full meta-analysis (Table 2) . Likewise, when the included studies were limited to those with a high NOS score (7), the pooled ORs of these 22 studies were not materially different from those of the full meta-analysis ( Table 2) .
Analysis of heterogeneity
Significant heterogeneity existed in the allelic model (I 2 ¼ 75.4%). A Galbraith plot was created to graphically assess the source of heterogeneity ( Figure 6 ). The studies by Figure 3 . Forest plot of the association between ATG16L1 and Crohn's disease using the additive model (GG versus AA). The pooled odds ratio (OR) and 95% confidence intervals (CI) are indicated by the diamond. Percentage weights were calculated using a fixed effects model.
Yamazaki et al., 17 Fowler et al. 19 (study 1), Latiano et al., 25 Amre et al., 31 Lacher et al., 34 Palomino-Morales et al., 37 Jung et al. 45 and Hirano et al. 47 were identified as contributors to the heterogeneity. When these eight studies were excluded, the I 2 was 0.0% and the OR (95% CI) was 1.33 (1.28, 1.37).
Publication bias
The shapes of the Begg's funnel plots did not reveal any evidence of obvious asymmetry (Figure 7) . No statistical evidence of publication bias was found using Egger's regression test (P ¼ 0.09 for the allelic model; P ¼ 0.62 for the additive model; P ¼ 0.08 Figure 4 . Forest plot of the association between ATG16L1 and Crohn's disease using the dominant model (GG þ GA versus AA). The pooled odds ratio (OR) and 95% confidence intervals (CI) are indicated by the diamond. Percentage weights were calculated using a fixed effects model. for the dominant model; and P ¼ 0.83 for the recessive model).
Discussion
Since Hampe et al. 5 reported in 2007 that ATG16L1 gene polymorphism was associated with Crohn's disease, many studies have evaluated the relationship between ATG16L1 and the risk of Crohn's disease. 56 However, the results are inconsistent. As the strength of results from a single case-control study is weak due to small sample sizes, the combination of many studies in a metaanalysis has the benefit of overcoming this limitation by increasing the sample size and Figure 5 . Forest plot of the association between ATG16L1 and Crohn's disease using the recessive model (GG versus GA þ AA). The pooled odds ratio (OR) and 95% confidence intervals (CI) are indicated by the diamond. Percentage weights were calculated using a fixed effects model. generating more robust results. Meta-analysis has been widely used in genetic association studies. 57, 58 The present meta-analysis was performed to assess whether the combined evidence supports an association between ATG16L1 and Crohn's disease.
The present meta-analysis examined ATG16L1 gene polymorphism and its relationship with the risk of Crohn's disease based on data from 47 case-control studies involving 18 638 cases and 30 181 controls. Most of these studies reported that ATG16L1 was associated with the risk of Crohn's disease, but not all. The results of the meta-analyses demonstrated that overall there was evidence of a significant association between ATG16L1 gene polymorphism and Crohn's disease. This significant association remained in all four genetic models when subgroup analyses were performed based on study design (populationbased or hospital-based).
When considering the potential mechanisms linking ATG16L1 polymorphism with an increased risk of Crohn's disease, it has been shown that ATG16L1 polymorphism impairs the autophagy processing of pathogenic bacteria and the function of intestinal Paneth cells. 59, 60 In addition, it has been shown that ATG16L1 polymorphism is associated with increased susceptibility to Helicobacter pylori infection. 61 In patients with Crohn's disease, it has been reported that homozygosity of the ATG16L1 risk allele (GG) was associated with a reduced ability to clear pathosymbionts. 62 Paneth cells in ATG16L1-deficient mice have been shown to be dysfunctional and to demonstrate increased expression of pro-inflammatory cytokines. 63, 64 When interpreting the results of this meta-analysis, a number of limitations should be acknowledged. First, it is well known that both environmental factors and individual genetic predisposition contribute to the development of Crohn's disease. Due to the lack of original data, however, 17 Fowler et al. 19 (study 1), Latiano et al., 25 Amre et al., 31 Lacher et al., 34 Palomino-Morales et al., 37 Jung et al. 45 and Hirano et al. 47 b, effect estimate; se, standard error.
potential interactions between these two types of influence has not been evaluated. Secondly, ATG16L1 seems to exert a close functional correlation with other genes in regulating autophagy. For example, the interaction of ATG16L1 and NOD2 has been implicated in the pathogenesis of Crohn's disease. 63 Potential gene-gene interactions require further evaluation. Thirdly, the ATG16L1 genotype has been reported to be associated with disease phenotype, 65 which has clinical significance. Further combined analyses are needed to clarify the association between the ATG16L1 genotype and Crohn's disease phenotype.
In conclusion, the present meta-analysis of robust data and unbiased results demonstrated an association between ATG16L1 genotype and the development of Crohn's disease. These findings will be helpful in understanding the aetiology of Crohn's disease and indicate that the ATG16L1 gene might have potential as a therapeutic or diagnostic target.
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